KEROS THERAPEUTICS INC. - COMMON STOCK

Keros Reinforces Commitment to Maximizing Stockholder Value

08 May 2025 17:31:00 By Nasdaq GlobeNewswire

Keros Therapeutics Reports Recent First Quarter 2025 Financial Results

06 May 2025 16:01:42 By Nasdaq GlobeNewswire

Keros Therapeutics Announces Review of Strategic Alternatives

10 Apr 2025 06:00:00 By Nasdaq GlobeNewswire

Keros Therapeutics Announces Initial Topline Results from the Phase 1 Clinical Trial of KER-065 in Healthy Volunteers

31 Mar 2025 06:00:00 By Nasdaq GlobeNewswire

Keros Therapeutics Announces Participation at Upcoming Healthcare Conferences

28 Feb 2025 17:00:00 By Nasdaq GlobeNewswire

Keros Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2024 Financial Results

26 Feb 2025 16:01:00 By Nasdaq GlobeNewswire

Keros Therapeutics to Present at the Guggenheim SMID Cap Biotech Conference

30 Jan 2025 08:00:00 By Nasdaq GlobeNewswire

Keros Therapeutics Announces Effectiveness of Global License Agreement with Takeda to Advance Elritercept

21 Jan 2025 08:00:00 By Nasdaq GlobeNewswire

Keros Therapeutics Announces Additional Update on the Phase 2 TROPOS Trial

15 Jan 2025 06:30:00 By Nasdaq GlobeNewswire

Keros Therapeutics Announces Update on the Phase 2 TROPOS Trial

12 Dec 2024 06:00:00 By Nasdaq GlobeNewswire

Keros Therapeutics Presents Clinical Data from its Elritercept Program at the 66th American Society of Hematology Annual Meeting and Exposition

09 Dec 2024 19:30:00 By Nasdaq GlobeNewswire

Keros Therapeutics Announces Global License Agreement with Takeda to Advance Elritercept

03 Dec 2024 07:00:00 By Nasdaq GlobeNewswire

Keros Therapeutics Announces Participation at Upcoming Healthcare Conferences

26 Nov 2024 08:00:00 By Nasdaq GlobeNewswire

Keros Therapeutics to Present at the Guggenheim Healthcare Innovation Conference

06 Nov 2024 08:00:00 By Nasdaq GlobeNewswire

Keros Therapeutics to Present at the 66th American Society of Hematology Annual Meeting and Exposition

05 Nov 2024 09:00:00 By Nasdaq GlobeNewswire

Keros Therapeutics Appoints Yung H. Chyung, M.D., as Chief Medical Officer

16 Oct 2024 08:00:00 By Nasdaq GlobeNewswire

Keros Therapeutics Announces Updated Time of Presentation at 2024 Cantor Global Healthcare Conference

12 Sep 2024 08:00:00 By Nasdaq GlobeNewswire

Keros Therapeutics Announces Update on Enrollment in the Phase 2 TROPOS Trial

03 Sep 2024 08:00:00 By Nasdaq GlobeNewswire

Keros Therapeutics Announces Participation at Upcoming Healthcare Conferences

28 Aug 2024 08:00:00 By Nasdaq GlobeNewswire

Keros Therapeutics Reports Second Quarter 2024 Financial Results

07 Aug 2024 16:01:00 By Nasdaq GlobeNewswire